Top

Clinical Orthopaedics and Related Research®

Published in:

01-04-2011 | Symposium: Periprosthetic Joint Infection

Structural Allograft as an Option for Treating Infected Hip Arthroplasty with Massive Bone Loss

Authors: Paul T. H. Lee, MB BCh, MA, FRCS (Eng), FRCS (Tr & Orth), Robert A. Clayton, MBBS, FRCS (Edin), FRCS (Tr & Orth), Oleg A. Safir, MD, FRCSC, MEd, David J. Backstein, MD, FRCSC, MEd, Allan E. Gross, MD, FRCSC, OOnt

Published in: Clinical Orthopaedics and Related Research® | Issue 4/2011

Abstract

Background

Revision of the infected hip arthroplasty with major bone loss is difficult. Attempts to restore bone stock with structural allograft are controversial.

Questions/purposes

We assessed the (1) reinfection rate; (2) rerevision rate; (3) radiographic graft union, resorption, and implant migration; (4) Harris hip scores at 1 year and at last followup compared with before surgery; and (5) other major complications associated with the use of bulk structural allograft to treat massive bone loss in infected hip arthroplasty.

Methods

We retrospectively reviewed 27 patients who underwent two-stage revision arthroplasty using structural allograft to treat massive bone defects in infected hip arthroplasty. There were 17 proximal femoral grafts, three acetabular major column grafts, two acetabular minor column grafts, and 10 cortical strut grafts used. Five patients had combinations of two allografts. The minimum followup was 1.1 years (mean, 8.2 years; range, 1.1–16.8 years).

Results

One of 27 patients had reinfection. The Kaplan-Meier survivorship was 93% at 10 years with rerevision for aseptic loosening as the end point. Radiographically, three patients had nonunion at the graft–host junction. All patients except two had graft resorption, of which all were mild except two, which were severe. Three patients had implant migration. The mean modified Harris hip scores were 39.2 points (range, 25–60) preoperatively, 67.3 points (range, 40–91) at 1-year followup, and 70.3 points (range, 46–81) at last followup. Other major complications included one patient with dislocation and one patient with transient sciatic nerve injury.

Conclusions

Based on our data, we believe the use of structural allografts is a reasonable option for treating massive bone loss in infected hip arthroplasties.

Level of Evidence

Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

Alexeef M, Mahomed N, Morsi E, Garbuz D, Gross A. Structural allograft in two-stage revision for failed septic hip arthroplasty. J Bone Joint Surg Br. 1996;78:213–216.

Allan DG, Lavoie GJ, McDonald S, Oakeshott R, Gross AE. Proximal femoral allografts in revision hip arthroplasty. J Bone Joint Surg Br. 1991;73:235–240.PubMed

Ammon P, Stockley I. Allograft bone in two-stage revision of the hip for infection. Is it safe? J Bone Joint Surg Br. 2004;86:962–965.PubMedCrossRef

Anract P, Coste J, Vastel L, Jeanrot C, Mascard E, Tomeno B. Proximal femoral reconstruction with megaprosthesis versus allograft prosthesis composite. A comparative study of functional results, complications and longevity in 41 cases [in French]. Rev Chir Orthop Reparatrice Appar Mot. 2000;86:278–288.PubMed

Bittar ES, Petty W. Girdlestone arthroplasty for infected total hip arthroplasty. Clin Orthop Relat Res. 1982;170:83–87.PubMed

Bourne RB, Hunter GA, Rorabeck CH, Macnab JJ. A six-year follow-up of infected total hip replacement managed by Girdlestone’s arthroplasty. J Bone Joint Surg Am. 1985;67:1074–1085.

Buttaro MA, Comba F, Pusso R, Piccaluga F. Acetabular revision with metal mesh, impaction bone grafting, and a cemented cup. Clin Orthop Relat Res. 2008;466:2482–2490.PubMedCrossRef

Dick HM, Strauch RJ. Infection of massive bone allografts. Clin Orthop Relat Res. 1994;306:46–53.PubMed

English H, Timperley D, Sunlop D, Gie G. Impaction grafting of the femur in two-stage revision for infected total hip replacement. J Bone Joint Surg Br. 2002;84:700–705.PubMedCrossRef

10.

Farid Y, Lin PP, Lewis VO, Yasko AW. Endoprosthetic and allograft-prosthetic composite reconstruction of the proximal femur for bone neoplasms. Clin Orthop Relat Res. 2006;442:223–229.PubMedCrossRef

11.

Fawcett K, Barr AR. Tissue Banking. Arlington, VA: American Association of Tissue Banks; 1987.

12.

Fountain JR, Dalby-Ball J, Carroll FA, Stockley I. The use of total femoral arthroplasty as a limb salvage procedure: the Sheffield experience. J Arthroplasty. 2007;22:663–669.PubMedCrossRef

13.

Gerber A, Pisan M, Zurakowski D, Isler B. Ganz reinforcement ring for reconstruction of acetabular defects in revision total hip arthroplasty. J Bone Joint Surg Am. 2003;85:2358–2364.PubMed

14.

Graham NM, Stockley I. The use of structural proximal femoral allograft in complex revision hip arthroplasty. J Bone Joint Surg Br. 2004;86:337–343.PubMedCrossRef

15.

Grauer JD, Amstutz HC, O’Carrol PF, Dorey FJ. Resection arthroplasty of the hip. J Bone Joint Surg Am. 1989;71:669–678.PubMed

16.

Gross AE. Revision arthroplasty of the hip using allograft bone. In: Czitrom AA, Gross AE, eds. Allografts in Orthopedic Practice. Baltimore, MD: Williams & Williams; 1992:147–173.

17.

Gross AE, Hutchinson CR. Proximal femoral allografts for reconstruction of bone stock in revision hip arthroplasty. Orthopedics. 1998:21:999–1001.PubMed

18.

Herrera A, Martínez AA, Cuenca J, Canales V. Management of types III and IV acetabular deficiencies with the longitudinal oblong revision cup. J Arthroplasty. 2006;21:857–864.PubMedCrossRef

19.

Hsieh PH, Shih CH, Chang YH, Lee MS, Yang WE, Shih HN. Treatment of deep infection of the hip associated with massive bone loss. J Bone Joint Surg Br. 2005;87:770–775.PubMedCrossRef

20.

Jasty M, Harris W. Salvage total hip reconstruction in patients with major acetabular bone deficiency using structural femoral head allografts. J Bone Joint Surg Br. 1990;72:63–67.PubMed

21.

Koster G, Rading S. Revision of failed acetabular components utilizing a cementless oblong cup: an average 9-year follow-up study. Arch Orthop Trauma Surg. 2009;129:603–608.PubMedCrossRef

22.

Lakstein D, Backstein DJ, Safir O, Kosashvili Y, Gross AE. Trabecular metal for acetabular defects with 50% of less host bone contact. Clin Orthop Relat Res. 2009;467:2318–2324.PubMedCrossRef

23.

Langlais F, Lambotte JC, Collin P, Thomazeau H. Long-term results of allograft composite total hip prosthesis for tumor. Clin Orthop Relat Res. 2003;414:197–211.PubMedCrossRef

24.

Lonner JH, Desai P, Dicesare PE, Sreiner G, Zuckerman JD. The reliability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J Bone Joint Surg Am. 1996;78:1553–1558.PubMed

25.

Lord CF, Gerhardt MC, Tomford WW, Mankin HJ. Infection in bone allografts: incidence, nature and treatment. J Bone Joint Surg Am. 1988;70:369–376.PubMed

26.

Mallory TH. Excision arthroplasty with delayed wound closure for the infected total hip replacement. Clin Orthop Relat Res. 1978;137:106–111.PubMed

27.

Massin P, Schmidt L, Engh CA. Evaluation of cementless acetabular component migration: an experimental study. J Arthroplasty. 1989;4:245–251.PubMedCrossRef

28.

Masterson EL, Duncan CP. Subsidence and the cement mantle in femoral impaction allografting. Orthopedics. 1997;20:821–822.PubMed

29.

McElwaine JP, Colville J. Excision arthroplasty for infected total hip replacements. J Bone Joint Surg Br. 1984;66:168–171.PubMed

30.

Medling JB, Ritter MA, Keating EM, Faris PM. Impaction bone grafting before insertion of a femoral stem with cement in revision total hip arthroplasty: a minimum two-year follow-up study. J Bone Joint Surg Am. 1997;79:1834–1841.

31.

Mowe JC. Standards for Tissue Banking. Arlington, VA: American Association of Tissue Banks; 1988.

32.

Murray D. The hip. In: Pynsent D, Fairbank J, Carr A, eds. Outcome Measurements in Orthopaedics. Oxford, UK: Butterworth-Heinemann; 1993:198–227.

33.

Nusem I, Morgan DAF. Structural allograft for bone stock reconstruction in two-stage revision for infected total hip arthroplasty. Good outcome in 16 of 18 patients followed up for 5–14 years. Acta Orthop. 2006;77:92–97.PubMedCrossRef

34.

Safir O, Kellett CF, Flint M, Backstein D, Gross AE. Revision of the deficient proximal femur with a proximal femoral allograft. Clin Orthop Relat Res. 2009;467:206–212.PubMedCrossRef

35.

Saleh KJ, Holtzman J, Gafni ASaleh L, Jaroszynski G, Wong P, Woodgate I, Davis A, Gross AE. Development, test reliability and validation of a classification for revision hip arthroplasty. J Orthop Res. 2001;19:50–56.PubMedCrossRef

36.

Schlegel UJ, Bitsch RG, Pritsch M, Clauss M, Mau H, Breusch SJ. Mueller reinforcement rings in acetabular revision: outcome in 164 hips followed for 2–17 years. Acta Orthop. 2006;77:234–241.PubMedCrossRef

37.

Siegmeth A, Duncan CP, Masri BS, Kim WY, Garbuz DS. Modular tantalum augments for acetabular defects in revision hip arthroplasty. Clin Orthop Relat Res. 2009;467:199–205.PubMedCrossRef

38.

Sporer SM, O’Rourke M, Chong P, Paprosky WG. The use of structural distal femoral allografts for acetabular reconstruction. Average ten-year follow-up. J Bone Joint Surg Am. 2005;87:760–765.PubMedCrossRef

39.

Haaren EH, Heyligers IC, Alexander FG, Wuisman PI. High rate of failure of impaction grafting in large acetabular defects. J Bone Joint Surg Br. 2007;89:296–300.PubMedCrossRef

40.

Wang JW, Chen CE. Reimplantation of infected hip arthroplasties using bone allografts. Clin Orthop Relat Res. 1997;335:202–210.PubMedCrossRef

41.

Woodgate I, Gross AE. Minor column structural acetabular allografts in revision hip arthroplasty. Clin Orthop Relat Res. 2000;371:75–85.PubMedCrossRef

42.

Zehr R, Enneking W, Scarborough M. Allograft-prosthesis composite versus megaprosthesis in proximal femoral reconstruction. Clin Orthop Relat Res. 1996;322:207–223.PubMedCrossRef

Title: Structural Allograft as an Option for Treating Infected Hip Arthroplasty with Massive Bone Loss
Authors: Paul T. H. Lee, MB BCh, MA, FRCS (Eng), FRCS (Tr & Orth)
Robert A. Clayton, MBBS, FRCS (Edin), FRCS (Tr & Orth)
Oleg A. Safir, MD, FRCSC, MEd
David J. Backstein, MD, FRCSC, MEd
Allan E. Gross, MD, FRCSC, OOnt
Publication date: 01-04-2011
Publisher: Springer-Verlag
Published in: Clinical Orthopaedics and Related Research® / Issue 4/2011
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI: https://doi.org/10.1007/s11999-010-1673-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Structural Allograft as an Option for Treating Infected Hip Arthroplasty with Massive Bone Loss

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Level of Evidence

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Level of Evidence

Please log in to get access to this content

Other articles of this Issue 4/2011

Acetabular Anteversion with CT in Supine, Simulated Standing, and Sitting Positions in a THA Patient Population

Greater Strength Increase with Cyst Decompression and SLAP Repair than SLAP Repair Alone

Risk Factors for Revision of Hip Arthroplasties in Patients Younger Than 30 Years

Current Concepts for Clean Air and Total Joint Arthroplasty: Laminar Airflow and Ultraviolet Radiation: A Systematic Review

The Sensitivity and Specificity of Ultrasound for the Diagnosis of Carpal Tunnel Syndrome: A Meta-analysis

Where to Tenodese the Biceps: Proximal or Distal?